SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The company witnessed a 21.23% growth in the revenue at Rs. 15883.90 millions for the quarter ended December 2023 as compared to Rs. 13102.10 millions during the year-ago period.Net profit surges 95.79% to Rs. 2332.40  millions  from Rs. 1191.30 millions in the quarter ended December 2023.Operating Profit saw a handsome growth to 3404.40 millions from 2248.10 millions in the quarter ended December 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 15883.90 13102.10 21.23 43995.00 38418.80 14.51 51490.00 50354.10 2.26
Other Income 33.00 5.90 459.32 240.90 15.90 1415.09 35.40 511.40 -93.08
PBIDT 3404.40 2248.10 51.43 7344.10 4967.30 47.85 6678.80 9599.50 -30.43
Interest 146.60 146.50 0.07 443.40 354.00 25.25 490.00 170.20 187.90
PBDT 3257.80 2101.60 55.02 6900.70 4613.30 49.58 6188.80 9429.30 -34.37
Depreciation 690.80 658.50 4.91 2020.10 1994.10 1.30 2729.50 2849.20 -4.20
PBT 2567.00 1443.10 77.88 4880.60 2619.20 86.34 3459.30 6580.10 -47.43
TAX 234.60 251.80 -6.83 234.60 457.40 -48.71 -8.00 1144.60 -100.70
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 2332.40 1191.30 95.79 4646.00 2161.80 114.91 3467.30 5435.50 -36.21
Equity 393.10 393.10 0.00 393.10 393.10 0.00 393.10 393.10 0.00
PBIDTM(%) 21.43 17.16 24.91 16.69 12.93 29.11 12.97 19.06 -31.96

Alembic Pharma Share Price

765.85 2.30 (0.30%)
22-Apr-2026 12:09 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1660.50
Dr. Reddys Lab 1220.55
Cipla 1233.50
Zydus Lifesciences 931.50
Lupin 2310.15
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×